Generic name:
Drug class:Atomoxetine
by Drugs.com. Last updated on Mar 10, 2025.
Atomoxetine is a selective norepinephrine reuptake inhibitor. It is used to treat certain types of attention-deficit hyperactivity disorder (ADHD) in children and adolescents (ADHD-P). It is also used to treat symptoms of attention-deficit hyperactivity disorder (ADHD-P) in adults with ADHD.
Atomoxetine is also used to treat symptoms of attention-deficit hyperactivity disorder (ADHD-P). It works by increasing levels of norepinephrine in the brain, which helps to increase the ability to focus and pay attention to events in the event-based system.
Atomoxetine may also be used for purposes not listed in this medication guide.
It is important to tell your doctor if you are experiencing any of the following symptoms:
• Persistent or persistent dry mouth
• Difficulty swallowing
• Difficulty breathing
• Chest pain
• Fever
• Sweating
• Flushing (warmth, redness, or tingly feeling)
If you are experiencing the above symptoms, speak to your pharmacist or doctor.
These are not all the possible symptoms of an allergic reaction to this drug. For a full list of possible side effects, as not all possible side effects from other medications, see the manufacturer's Patient Information leaflet.
Atomoxetine is usually prescribed in one dose and maintenance. The dose can be adjusted as needed, depending on your doctor's instructions. Your doctor may start you on a lower dose or change your dose as needed. Your doctor may start you on a higher dose, and gradually increase your dose to get the most benefit.
It is important to tell your doctor about all the medicines you are taking including prescription and non-prescription medicines, vitamins, and herbal products. Ask your doctor about any other medicines you are taking. This includes over-the-counter medicines, herbal medicines, and dietary supplements.
Your doctor may stop you from taking atomoxetine in case of accidental overdose.
It is important to take your medicine exactly as your doctor tells you to take it. Do not stop taking your medicine abruptly, or change the dose regularly without your doctor's advice. Stopping your medicine too early may cause serious side effects. If you take too much atomoxetine, you may get some side effects such as:
Tell your doctor about all the medicines you are taking, including any supplements or herbal medicines that you are taking. This includes prescription and non-prescription medicines, vitamins, and vitamins. This includes prescription medicines, herbal products, and dietary supplements. Ask your doctor about any other medicines and herbal products you are taking.
To reduce the development of drug-resistant bacteria and maintain the effectiveness of atomoxetine, your doctor may start you on a lower dose. Your doctor may gradually increase your dose to get the most benefit from it.
Tell your doctor if you have any other medical conditions, especially if any of the following apply to you:
Published on January 14, 2020
AstraZeneca today announced the release of its new Strattera Strattera Study Group, which is an experimental research program of the U. S. Pharmacopeial Convention, which was designed to test the safety and efficacy of atomoxetine for ADHD treatment.
The study, known as Strattera, will evaluate the safety and efficacy of atomoxetine in adolescents and adults with ADHD in two different groups: those under 18 and those 18 years of age.
Atomoxetine is known to be an atypical (at least in pediatric populations) selective norepinephrine reuptake inhibitor (SNRI). The FDA has approved atomoxetine in pediatric and adults over 18 years of age, with safety studies in both groups being planned.
In order to assess the safety of atomoxetine in patients, the safety studies were conducted in children under 18 and children aged 18 years and older.
AstraZeneca has submitted data to the FDA for the atomoxetine studies, which are being conducted to evaluate the safety of atomoxetine in pediatric patients ages 18 years and older, which have not yet been approved.
AstraZeneca will conduct a safety review of atomoxetine, including the development of the atomoxetine studies, and conduct a study review of atomoxetine in children.
The study will be conducted in the United States, Canada, Australia and New Zealand.
The Strattera Strattera Study Group is an open-label, randomized, double-blind, placebo-controlled, parallel-group, multicenter, parallel-design study designed to evaluate the efficacy and safety of atomoxetine in adolescents and adults with ADHD treated in the United States and Canada for at least two years.
The Strattera Strattera Study Group will enroll more than 2,200 patients in the United States, Canada, Australia and New Zealand. This study will be conducted at a mean annual cost of approximately $7,000.
The studies will be performed in pediatric patients aged 3 to 17 years, or 6 to 18 years of age, who have not yet received atomoxetine or who are not currently using the drug.
Atomoxetine is indicated for the treatment of attention-deficit/hyperactivity disorder (ADHD), obsessive-compulsive disorder, panic disorder, and social phobia. Atomoxetine is also indicated for the treatment of attention-deficit/hyperactivity disorder in adolescents and adults. For the treatment of anxiety disorders, atomoxetine is indicated for the treatment of generalized anxiety disorder.
Atomoxetine is approved by the FDA for the treatment of ADHD, generalized anxiety disorder, and major depressive disorder. The Food and Drug Administration (FDA) also approves the use of atomoxetine in the treatment of ADHD in children.
Atomoxetine is the only FDA-approved drug for the treatment of ADHD in adults. The drug was approved for the treatment of ADHD in adolescents 12 years of age and older, and is also approved for the treatment of generalized anxiety disorder in adults.
The Strattera Strattera Study Group is also conducting a phase 1, double-blind, placebo-controlled, multicenter, parallel-design study to evaluate the efficacy and safety of atomoxetine in the treatment of ADHD in adolescents 12 years and older.
The Strattera Strattera Study Group will enroll more than 6,500 patients in the United States, Canada, Australia and New Zealand, and have enrolled patients aged 3 to 17 years and older who have not yet received atomoxetine.
Atomoxetine has been shown to be more effective than placebo in both children and adolescents with ADHD, but has also been shown to be more effective than placebo in children who do not have ADHD.
The Strattera Strattera Study Group will enroll more than 2,000 patients in the United States, Canada, Australia and New Zealand, and have enrolled patients aged 3 to 17 years and older, who have not yet received atomoxetine.
In addition, the study will be conducted in the United States, Canada, Australia and New Zealand.
Atomoxetine is the only FDA-approved drug for the treatment of ADHD, and has been approved by the FDA for the treatment of ADHD in adults.
I hope that by following the above guidelines, I will be able to get you started on the Strattera (atomoxetine) dose. I am going to provide a link to the information on this drug and also provide some more details about it on my website, so if you want to read more about it, I will be sure to give you a copy of the information.
Atomoxetine works by increasing levels of a substance called norepinephrine. It is not a stimulant. It doesn't make you feel sleepy and you don't feel drowsy. You don't need to sleep in a bed, but it can be taken. You will get a little tired in the morning and you can relax by lying down.
The drug can help to improve mood and reduce aggression in people with ADHD and have some of the benefits listed above. In adults, the drug is used to treat ADHD.
Atomoxetine is a stimulant that works by increasing the levels of norepinephrine and dopamine. This increase in norepinephrine can help to improve attention and memory and may also help to reduce aggression.
Atomoxetine can also be used in people who have not yet gotten an ADHD diagnosis and in people who have not yet had a diagnosis for ADHD.
Atomoxetine is also used in people with a history of allergic reaction to certain medications or foods.
It is also used in people who have high blood pressure, heart problems, kidney problems, liver disease, seizures, and high cholesterol.
It is used to treat conditions such as asthma, whooping cough, and other lung and throat problems.
Atomoxetine is not used as a full antidepressant.
The side effects of Atomoxetine can include insomnia, anxiety, and sweating. These side effects are more common with the use of atomoxetine.
Atomoxetine is not used for depression. It can be used to treat conditions such as anxiety, bipolar disorder, and insomnia.
It is not habit forming. It should not be taken in the last 3 months of pregnancy.
Atomoxetine is not prescribed to anyone with dementia.
It should not be taken by anyone who is at high risk of developing suicide or suicide attempts.
Atomoxetine should not be used in the first month of treatment.
Atomoxetine should not be taken after the age of 18.
Atomoxetine is not approved for use in children.
It is not used for children under the age of 18. It should not be used for children who are not growing or showing signs of getting in trouble for being too sleepy.
The dose of atomoxetine used for children should not be increased more than the dose used for adults.
The dosage of atomoxetine used for children should not be increased more than the dosage for adults.
Atomoxetine should not be used in children younger than 8 years old.
Atomoxetine is not approved for use in children under the age of 18.
Atomoxetine is not approved for use in children under the age of 8.
Atomoxetine should not be used for children younger than 8 years old.
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
This product is temporarily unavailable.
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
HealthylifeHealthylife provides general product information like price, type, and brand of medicine, but does not recommend or require a prescription. If you are experiencing a medical emergency, contact us at [email protected]. Always read the label and follow the directions for use for all products on our website. For therapeutic goods, always read the label and follow the directions for use.
Healthylife requires a prescription before purchase. Product details are provided with a pharmacist's contact information along with any other medical information you provide to Healthylife. Prescription medicines are issued by a licensed medical professional with a valid prescription. If you have any questions or concerns, please feel free to contact the manufacturer.
Healthylife does not require a prescription to purchase this product. Healthylife requires a valid prescription from a licensed medical professional before you can purchase this product.
Strattera is an antidepressant that has been approved by the U. S. Food and Drug Administration (FDA) to treat adults and adolescents. It is an atypical antipsychotic used to treat ADHD. Strattera is also marketed as Strattera SR (atomoxetine), Strattera XR (atomoxetine hydrochloride), Strattera XL (atomoxetine hydrochloride), and Strattera ODT (atomoxetine hydrochloride).
Strattera works by affecting the levels of certain neurotransmitters in the brain, including dopamine, norepinephrine, and serotonin. It acts by blocking these chemicals, thus leading to increased activity in the brain. The active ingredient in Strattera is atomoxetine hydrochloride, a selective serotonin reuptake inhibitor (SSRI).
The primary component of Strattera is atomoxetine hydrochloride, which is the same active ingredient found in atomoxetine. The exact same molecule in the drug is used to treat ADHD, but there are differences in how they work, which is how they should work. Atomoxetine belongs to a class of drugs called selective serotonin reuptake inhibitors (SSRIs). Strattera works by increasing serotonin levels in the brain, which can help improve attention, mood, and behavior.
Stade de France Pharmacy